CD Bloomfield

3.7k total citations
34 papers, 2.2k citations indexed

About

CD Bloomfield is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, CD Bloomfield has authored 34 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 15 papers in Public Health, Environmental and Occupational Health and 11 papers in Genetics. Recurrent topics in CD Bloomfield's work include Acute Myeloid Leukemia Research (20 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Lymphocytic Leukemia Research (9 papers). CD Bloomfield is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Lymphocytic Leukemia Research (9 papers). CD Bloomfield collaborates with scholars based in United States, Finland and Germany. CD Bloomfield's co-authors include DC Arthur, BA Peterson, FR Davey, RK Dodge, Albert de la Chapelle, CA Schiffer, R. John Mayer, O. Margaret Garson, Guido Marcucci and DD Hurd and has published in prestigious journals such as Blood, Leukemia and International Journal of Oncology.

In The Last Decade

CD Bloomfield

34 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
CD Bloomfield United States 21 1.6k 918 666 513 394 34 2.2k
G. John Swansbury United Kingdom 25 1.3k 0.8× 686 0.7× 583 0.9× 655 1.3× 411 1.0× 43 2.0k
Preben Philip Denmark 25 1.8k 1.1× 879 1.0× 978 1.5× 628 1.2× 404 1.0× 69 2.8k
FR Davey United States 14 1.1k 0.7× 722 0.8× 372 0.6× 391 0.8× 227 0.6× 32 1.6k
Martha G. Sensel United States 24 1.3k 0.8× 1.7k 1.9× 603 0.9× 262 0.5× 210 0.5× 42 2.8k
Itsuro Jinnai Japan 20 1.9k 1.2× 729 0.8× 621 0.9× 647 1.3× 122 0.3× 79 2.3k
Giovanna Rege‐Cambrin Italy 21 1.4k 0.9× 669 0.7× 612 0.9× 893 1.7× 199 0.5× 70 2.0k
Mario Sessarego Italy 28 1.8k 1.1× 465 0.5× 425 0.6× 882 1.7× 189 0.5× 122 2.3k
Toshiko Motoji Japan 26 1.5k 1.0× 366 0.4× 915 1.4× 700 1.4× 259 0.7× 121 2.6k
R. Kuse Germany 26 1.4k 0.9× 412 0.4× 518 0.8× 703 1.4× 763 1.9× 78 2.4k
Jl. Michaux Belgium 22 1.0k 0.7× 359 0.4× 307 0.5× 742 1.4× 287 0.7× 68 1.6k

Countries citing papers authored by CD Bloomfield

Since Specialization
Citations

This map shows the geographic impact of CD Bloomfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CD Bloomfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CD Bloomfield more than expected).

Fields of papers citing papers by CD Bloomfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CD Bloomfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CD Bloomfield. The network helps show where CD Bloomfield may publish in the future.

Co-authorship network of co-authors of CD Bloomfield

This figure shows the co-authorship network connecting the top 25 collaborators of CD Bloomfield. A scholar is included among the top collaborators of CD Bloomfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CD Bloomfield. CD Bloomfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Marcucci, Guido, MA Caligiuri, H. Döhner, et al.. (2001). Quantification of CBFβ/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia. Leukemia. 15(7). 1072–1080. 95 indexed citations
4.
Baer, MR, Kristiina Heinonen, Krzysztof Mrózek, et al.. (1996). Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia. Blood. 87(4). 1484–1494. 41 indexed citations
5.
Jurlander, Jesper, MA Caligiuri, Tapani Ruutu, et al.. (1996). Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood. 88(6). 2183–2191. 114 indexed citations
6.
Neubauer, Andreas, RK Dodge, SL George, et al.. (1994). Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood. 83(6). 1603–1611. 149 indexed citations
7.
Arthur, DC, et al.. (1989). Four new recurring translocations in non-Hodgkin lymphoma. Blood. 74(5). 1796–1800. 4 indexed citations
8.
Bloomfield, CD, Giuliana Alimena, Roland Berger, et al.. (1986). Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood. 67(2). 415–420. 234 indexed citations
9.
Keinänen, Mauri, Sakari Knuutila, CD Bloomfield, Erkki Elonen, & Albert de la Chapelle. (1986). The proportion of mitoses in different cell lineages changes during short-term culture of normal human bone marrow. Blood. 67(5). 1240–1243. 14 indexed citations
10.
Griffin, JD, Roger B. Davis, FR Davey, et al.. (1986). Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood. 68(6). 1232–1241. 168 indexed citations
11.
Griffin, JD, D. A. Nelson, FR Davey, et al.. (1986). Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood. 68(6). 1232–1241. 9 indexed citations
12.
Sobol, RE, et al.. (1985). Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies. Blood. 65(3). 730–735. 6 indexed citations
14.
Bloomfield, CD, et al.. (1983). Glucocorticoids and lymphocytes. III. Effects of glucocorticoid administration on lymphocyte glucocorticoid receptors. Blood. 61(6). 1086–1090. 2 indexed citations
15.
Bloomfield, CD, et al.. (1982). Translocation 4; 11 in acute lymphoblastic leukemia: clinical characteristics and prognostic significance. Blood. 59(1). 96–99. 134 indexed citations
16.
Arthur, DC, et al.. (1982). Translocation 4; 11 in acute lymphoblastic leukemia: clinical characteristics and prognostic significance. Blood. 59(1). 96–99. 104 indexed citations
17.
Peterson, BA & CD Bloomfield. (1981). Long-term disease-free survival in acute nonlymphocytic leukemia. Blood. 57(6). 1144–1147. 1 indexed citations
18.
Peterson, BA, et al.. (1981). 5-Azacytidine and renal tubular dysfunction. Blood. 57(1). 182–185. 36 indexed citations
19.
Peterson, BA, et al.. (1981). 5-Azacytidine and renal tubular dysfunction. Blood. 57(1). 182–185. 31 indexed citations
20.
McKenna, RW, CD Bloomfield, Fred R. Dick, ME Nesbit, & RD Brunning. (1975). Acute monoblastic leukemia: diagnosis and treatment of ten cases. Blood. 46(4). 481–494. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026